Patent · US Active

Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application

US9150544B2 · kind B2 · utility

0Cited by

2References

23Claims

0Family size

Assignee

Sanofi · FR

Inventors

Nathalie Alet · Paris, FR
Jean-Michel Altenburger · Le Puy-en-Velay, FR
Jean-Pascal Herault · Paris, FR
Reinhard Kirsch · Braunschweig, DE
Gilbert Lassalle · Paris, FR
Sergio Mallart · Paris, FR
Marie-Claire Philippo-Orts · Paris, FR

Key dates

Filing date	Dec 19, 2012
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Dec 19, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new sulphonylaminopyrrolidinone compounds having antithrombotic activity which, in particular, inhibit blood clotting factor IXa and/or factor Xa, to processes for their preparation and to use thereof as drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.